Clinical Trial Update: A Study of PLB-002 in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for PLB-002 in an advanced solid tumor population, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• PLB-002

Snippet

Sponsor: Primelink BioTherapeitics(ShenZhen) Limited | Conditions: Advanced Solid Tumor | Phase 1 | Status: RECRUITING